Artificial Intelligence in Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Application (Screening & Diagnosis, Tumor Identification, Surveillance, and Treatment), Cancer Type, End Use, and Region (North America, Europe, Asia Pa

The artificial intelligence (AI) in cancer diagnostics market size is expected to reach USD 2,174.26 million by 2034, according to a new study by Polaris Market Research. The report “Artificial Intelligence in Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Application (Screening & Diagnosis, Tumor Identification, Surveillance, and Treatment), Cancer Type, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The artificial intelligence in cancer diagnostics market involves the application of AI technologies, including machine learning and deep learning, to enhance the accuracy, efficiency, and speed of cancer detection and diagnosis. AI-powered solutions analyze medical imaging, pathology slides, and genomic data to assist healthcare professionals in identifying cancerous cells and predicting disease progression. The market is experiencing significant growth due to the increasing prevalence of cancer, rising demand for early detection, and advancements in AI-driven imaging and diagnostic tools. Growing adoption of AI in personalized medicine, increasing regulatory approvals, and expanding cloud-based AI solutions are further driving market expansion. The artificial intelligence in cancer diagnostics market opportunities exist in developing AI models for early-stage cancer detection, integrating AI with multi-omics data, and expanding accessibility in emerging markets. As investments in AI-driven healthcare solutions continue to rise, the market is expected to evolve with enhanced capabilities, improved clinical workflows, and greater integration into routine diagnostics.

Artificial Intelligence (AI) in Cancer Diagnostics Market Report Highlights

The screening & diagnosis segment, based on application, held the largest share of the artificial intelligence in cancer diagnostics market revenue in 2024 due to the widespread adoption of AI-driven imaging solutions for early cancer detection. The tumor identification segment is witnessing the fastest growth as AI models improve accuracy in distinguishing malignant and benign tumors.

By cancer type, the breast cancer segment accounted for the largest market share in 2024 due to high global incidence rates and significant AI advancements in mammography. Lung cancer is the fastest-growing segment, driven by increasing demand for AI-powered CT scan analysis and early-stage detection solutions.

North America led the artificial intelligence in cancer diagnostics market share in 2024 due to strong healthcare infrastructure, high AI adoption, and supportive regulatory policies. Asia Pacific is the fastest-growing region, driven by increasing healthcare digitization, rising cancer prevalence, and growing investments in AI-based diagnostics.

Several companies in the market are actively contributing to advancements in early detection and treatment. Microsoft Corporation, IBM Corporation, Siemens Healthineers, GE Healthcare, and Tempus Labs, Inc. are a few notable entities. These organizations are at the forefront of integrating AI into healthcare to enhance diagnostic accuracy and patient outcomes.

Polaris Market Research has segmented the artificial intelligence (AI) in cancer diagnostics market report on the basis of application, cancer type, end use, and region:

By Application Outlook (Revenue – USD Million, 2020–2034)

Screening & Diagnosis

Tumor Identification

Surveillance

Treatment

By Cancer Type Outlook (Revenue – USD Million, 2020–2034)

Breast Cancer

Prostate Cancer

Lung Cancer

Colorectal Cancer

Cervical Cancer

Others

By End Use Outlook (Revenue – USD Million, 2020–2034)

Hospitals

Diagnostic Centers

Medical Research Institute

Contract Research Organization

Other

By Regional Outlook (Revenue – USD Million, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America